spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  STEMI patients 

 HSMN NewsFeed - 24 May 2018
PiCSO therapy reduces infarct size in STEMI patients
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Apr 2015
InspireMD Announces Completion of Sales Restructuring Program
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 20 May 2014
InspireMD to Showcase Embolic Systems with MicroNet(TM) Technology and Results from MASTER I Trial at EuroPCR Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Dec 2013
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
Devices Interventional Personnel
 HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 Sep 2013
InspireMD Announces New Appointment to the Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 31 Jul 2013
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2013
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2013
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 14 Feb 2013
Miracor Granted Five Additional U.S. Patents and One Additional European Patent for Its PICSO(R) System to Treat Severe Heart Attack Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Jan 2013
Velomedix Receives Health Canada Approval for VELOCITY Pilot Study and Bolsters Leadership Team
Devices Cardiology Regulatory
 HSMN NewsFeed - 4 Dec 2012
Clinical study results using Miracor’s PICSO(R) system show potential to treat severe heart attack (STEMI) patients and are published in December’s Journal of Interventional Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Nov 2012
BIOTRONIK Launches the 3Flow Aspiration Catheter for Improved Thrombus Aspiration
Devices Interventional
 HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Jun 2012
Asher Holzer Retires as President of InspireMD
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 28 Feb 2012
Miracor receives $3.5 million cash infusion to begin pivotal clinical “RAMSES” trial of its PICSO system, designed to improve myocardial perfusion following primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Nov 2011
Miracor to Report Successful Clinical Study Results of Its PICSO(R) System Designed to Improve Myocardial Perfusion Following Primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Sep 2011
Abiomed Announces First Patient Enrolled In MINI-AMI Study
Devices Cardiology
 HSMN NewsFeed - 11 May 2011
Accumetrics Signs National Distribution Agreement with Cardinal Health
Diagnostics Personalized Medicine Cardiology Distribution
 HSMN NewsFeed - 2 Dec 2010
Abiomed Receives Conditional FDA Approval for Study with Impella 2.5 in Reducing Heart Muscle Damage Following PCI in STEMI Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 9 Feb 2010
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Devices Interventional Cardiology Acquisitions
 HSMN NewsFeed - 22 Sep 2009
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Safe in a Broad Population of Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2009
Stentys Establishes U.S. Operations in Princeton, N.J.
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2008
Datascope Announces New Clinical Trial of Intra-Aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction to Expand Market Utilization
Devices Cardiology
 HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Apr 2008
Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Mar 2008
Drug-Eluting Stents Outperform Bare Stents in Heart Attack
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 5 Mar 2008
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 29 Jan 2008
The Medicines Company's Angiox(R) Receives European Authorization for Expanded Use in Patients with Acute Coronary Syndromes (ACS)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 11 Dec 2007
Heartscape Technologies Appoints Former Medtronic Executive to Role as Chairman and Independent Director
Devices Personnel
 HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 24 Apr 2007
Heartscape Technologies Announces Close of Series B Funding
Devices Cardiology Venture Capital
 HSMN NewsFeed - 7 Feb 2007
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 Nov 2006
Heartscape Enrolls First Patient in OCCULT-MI Clinical Trial Using its PRIME ECG(R) System
Devices Cardiology
 HSMN NewsFeed - 7 Sep 2006
European commission expands indication for PLAVIX® (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack
Biopharmaceuticals Cardiology Regulatory
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
STEMI patients
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.